Johnson & Johnson (J&J) recently announced a significant shift in their approach to the 340B drug discount program, aiming to change how discounts are offered for crucial medications. This policy adjustment is set to take effect on October 15, 2024, and has raised considerable concerns
In recent years, the focus on perioperative care for older patients has become a critical concern, particularly for those undergoing elective hip and knee replacements. This concern is emphasized in Australia, where a significant population of elderly individuals requires such surgeries. A
The current status of mpox in Wales, as confirmed by Public Health Wales, provides a cautious yet reassuring outlook for the region. With no cases of Clade I mpox or any other variant reported within Wales, Public Health Wales maintains that the overall risk to the UK population remains low.
CluePoints, a standout innovator in the pharmaceutical and healthcare sectors, is spearheading significant changes through advancements in Risk-Based Quality Management (RBQM) and centralized monitoring. This article delves into various facets of these developments, drawing insights from Francois
In a significant move poised to revolutionize the pharmaceutical supply chain, LSPedia, a leader in SaaS solutions for global product traceability, has announced a strategic partnership with Pharma Logistics, a front-runner in pharmaceutical reverse distribution. This collaboration promises to set
The pharmaceutical industry plays a crucial role in developing medications that save and improve lives. This sector is characterized by a complex interplay of market forces, regulatory frameworks, and legal precedents that impact competition, pricing, and access to medicines. Understanding how
